IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2016. The put-call ratio across all filers is 269.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $248,000 | +28.5% | 14,881 | -2.3% | 0.00% | 0.0% |
| Q1 2017 | $193,000 | -74.4% | 15,233 | -73.2% | 0.00% | -75.0% |
| Q4 2016 | $754,000 | -87.0% | 56,893 | -76.7% | 0.00% | -86.2% |
| Q3 2016 | $5,785,000 | +71.0% | 244,090 | +130.9% | 0.03% | +45.0% |
| Q1 2016 | $3,384,000 | +832.2% | 105,692 | +1143.4% | 0.02% | +900.0% |
| Q4 2015 | $363,000 | -92.7% | 8,500 | -94.0% | 0.00% | -92.9% |
| Q3 2015 | $4,957,000 | +99040.0% | 140,762 | +140662.0% | 0.03% | – |
| Q2 2015 | $5,000 | -98.4% | 100 | -99.2% | 0.00% | -100.0% |
| Q3 2014 | $305,000 | -88.5% | 12,884 | -87.2% | 0.00% | -92.3% |
| Q1 2014 | $2,650,000 | +414.6% | 100,313 | +287.7% | 0.03% | +333.3% |
| Q2 2013 | $515,000 | – | 25,873 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |